← Back to all trials
Completed
NCT04323722
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
Conditions: Rectal Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 53
Sponsor: Institut Cancerologie de l'Ouest
Location: Institut de Cacerologie de l'ouest - site Paul Papin Angers
Summary
This trial is assessing how Bladder filling variations and thus mesorectal movements are less when radiotherapy treatment is received with an empty bladder in rectal cancer
Eligibility Criteria
Inclusion Criteria:
* Histologically confirmed rectal adenocarcinoma
* T2 N+ or T3 any N, eligible for radiotherapy or neo-adjuvant radio-chemotherapy treatment in a long course of 25 fractions
* Performance Status less or equal to 2
* Male or female 18 Years and older
* Creatinine clearance greater than or equal to 50ml/min
* Fertile patients must use effective contraception
* Written informed consent
* Patient must be affiliated to a Social Health Insurance
Exclusion Criteria:
* Previous treatment with pelvic radiotherapy
* Chronic inflammatory bowel disease in flare-up.
* Urinary catheterization, urinary diversion or cystectomy
* Hip prosthesis
* History of prostatectomy, or hysterectomy
* Urinary incontinence \> 2
* Pregnant or nursing patient
* Persons deprived of their liberty, as well as adults subject to a legal protection measure
* Impossibility to submit to the medical follow-up of this clinical trial for geographical, social or psychological reasons
Source: ClinicalTrials.gov (NCT04323722). StuddyBuddy aggregates publicly available trial information.